Bristol Myers Squibb Co (CELG-RI) SEC Filings — 2024
18 SEC filings for Bristol Myers Squibb Co (CELG-RI) in 2024.
Filings
- Bristol Myers Squibb Co SC 13G/A Filing — SC 13G/A · Nov 13, 2024
- Bristol Myers Squibb Q3 Sales Dip Slightly — 10-Q · Oct 31, 2024
- Bristol Myers Squibb Co SC 13G Filing — SC 13G · Oct 4, 2024
- Bristol Myers Squibb Q2 Sales Rise to $23.1B — 10-Q · Jul 26, 2024
- Bristol Myers Squibb Elects New Directors, Updates CFO Compensation — 8-K · Jun 18, 2024
- Bristol Myers Squibb Files 8-K on Shareholder Votes & Financials — 8-K · May 9, 2024
- Bristol Myers Squibb Co. Files 10-Q for Period Ending March 31, 2024 — 10-Q · Apr 25, 2024
- Bristol-Myers Squibb Files Proxy Materials — DEFA14A · Apr 22, 2024
- Bristol Myers Squibb Files Definitive Proxy Statement — DEF 14A · Mar 28, 2024
- Bristol Myers Squibb Files 8-K with Financial Updates — 8-K · Mar 18, 2024
- Bristol-Myers Squibb Files 8-K on Debt and Contingent Value Rights — 8-K · Feb 22, 2024
- Bristol Myers Squibb Reports Officer Changes, Compensation Arrangements — 8-K · Feb 15, 2024
- Bristol-Myers Squibb Files Routine 8-K on Securities Status — 8-K · Feb 14, 2024
- Bristol Myers Squibb Co SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Bristol Myers Squibb Co. Files 2023 Annual Report on Form 10-K — 10-K · Feb 13, 2024
- Bristol-Myers Squibb 8-K: Financial Condition & Operations Update — 8-K · Feb 2, 2024
- BlackRock Amends BMS Stake: Passive Investment Update — SC 13G/A · Jan 25, 2024
- Bristol-Myers Squibb Registers Securities on NYSE — 8-K · Jan 8, 2024